Yifeng Pharmacy Chain Co., Ltd. (SHA: 603939)
China
· Delayed Price · Currency is CNY 23.55
-0.41 (-1.71%)
Nov 21, 2024, 3:00 PM CST
Yifeng Pharmacy Chain Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 1,523 | 1,412 | 1,262 | 887.88 | 743.52 | 543.75 | Upgrade
|
| Depreciation & Amortization | 1,628 | 1,628 | 1,441 | 1,191 | 941.94 | 94.72 | Upgrade
|
| Other Amortization | 203.51 | 203.51 | 145.38 | 117.19 | 97.32 | 95.76 | Upgrade
|
| Loss (Gain) From Sale of Assets | -29.09 | -29.09 | -12.84 | -6.85 | -0.32 | 0.88 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 1.43 | 1.58 | 0.3 | Upgrade
|
| Loss (Gain) From Sale of Investments | -42.37 | -42.37 | -6.87 | -34.37 | -29.42 | -11.18 | Upgrade
|
| Provision & Write-off of Bad Debts | 4.54 | 4.54 | 10.47 | 4.41 | 6.32 | 4.25 | Upgrade
|
| Other Operating Activities | 750.67 | 402.11 | 382.81 | 313.34 | 318.25 | 127.06 | Upgrade
|
| Change in Accounts Receivable | -258.28 | -258.28 | -1,013 | -600.7 | -275.83 | -348.31 | Upgrade
|
| Change in Inventory | -261.54 | -261.54 | -459.39 | -885.07 | -342.08 | -300.49 | Upgrade
|
| Change in Accounts Payable | 1,543 | 1,543 | 2,140 | 1,177 | 851.31 | 749.24 | Upgrade
|
| Change in Other Net Operating Assets | 42.4 | 42.4 | 23.16 | 19.27 | 38.45 | 18.84 | Upgrade
|
| Operating Cash Flow | 5,084 | 4,624 | 3,920 | 2,150 | 2,330 | 963.23 | Upgrade
|
| Operating Cash Flow Growth | 13.12% | 17.94% | 82.34% | -7.71% | 141.86% | 88.61% | Upgrade
|
| Capital Expenditures | -796.24 | -739.92 | -587.51 | -827.54 | -582.8 | -459.29 | Upgrade
|
| Sale of Property, Plant & Equipment | 16.23 | 15.78 | 9.03 | 6.52 | 3.88 | 2.26 | Upgrade
|
| Cash Acquisitions | -350.34 | -498.82 | -450.56 | -408.88 | -138.93 | -491.19 | Upgrade
|
| Investment in Securities | -1,728 | -1,781 | -250.05 | 632 | -531.02 | 52.96 | Upgrade
|
| Other Investing Activities | -2,041 | 23.91 | 5.08 | 31.06 | -6.67 | 9.54 | Upgrade
|
| Investing Cash Flow | -4,899 | -2,980 | -1,274 | -566.84 | -1,256 | -885.73 | Upgrade
|
| Long-Term Debt Issued | - | - | 80 | 142.12 | 1,948 | 45 | Upgrade
|
| Long-Term Debt Repaid | - | -1,687 | -1,483 | -2,083 | -1,082 | -73.2 | Upgrade
|
| Net Debt Issued (Repaid) | 127.32 | -1,687 | -1,403 | -1,940 | 865.5 | -28.2 | Upgrade
|
| Issuance of Common Stock | 0.64 | 7.39 | 77.41 | - | 23.83 | 60.53 | Upgrade
|
| Repurchase of Common Stock | -3.52 | -3.52 | -2.85 | -1.69 | -2.22 | - | Upgrade
|
| Common Dividends Paid | -533.83 | -321.88 | -235.02 | -211.89 | -164.04 | -157.48 | Upgrade
|
| Other Financing Activities | -233.62 | -87.91 | -91.56 | -30.96 | -9.27 | -0.2 | Upgrade
|
| Financing Cash Flow | -643.01 | -2,093 | -1,655 | -2,185 | 713.8 | -125.36 | Upgrade
|
| Net Cash Flow | -458.74 | -449.62 | 991 | -601.88 | 1,788 | -47.85 | Upgrade
|
| Free Cash Flow | 4,287 | 3,884 | 3,333 | 1,322 | 1,747 | 503.95 | Upgrade
|
| Free Cash Flow Growth | 7.48% | 16.53% | 152.02% | -24.30% | 246.63% | 88.71% | Upgrade
|
| Free Cash Flow Margin | 17.92% | 17.19% | 16.76% | 8.63% | 13.29% | 4.90% | Upgrade
|
| Free Cash Flow Per Share | 3.54 | 3.21 | 2.75 | 1.10 | 1.51 | 0.44 | Upgrade
|
| Cash Income Tax Paid | 1,516 | 1,308 | 1,053 | 746.51 | 771.37 | 687.75 | Upgrade
|
| Levered Free Cash Flow | 4,046 | 3,203 | 3,123 | 1,096 | 1,934 | 356.53 | Upgrade
|
| Unlevered Free Cash Flow | 4,170 | 3,304 | 3,226 | 1,201 | 2,050 | 385.15 | Upgrade
|
| Change in Net Working Capital | -1,747 | -912.9 | -999.42 | 160.22 | -810.84 | -116.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.